Bayer reported EUR13.74B in Sales Revenues for its fiscal quarter ending in March of 2025.

Sales Change Date
Air Liquide EUR 7.03B 6.35B Dec/2024
Akzo Nobel EUR 2.61B 10M Mar/2025
Alcon AG USD 2.45B 30M Mar/2025
Amarin USD 42.3M 25.19M Sep/2024
Arkema EUR 2.38B 110M Mar/2025
AstraZeneca USD 13.59B 1.3B Mar/2025
BASF EUR 17.4B 1.54B Mar/2025
Bayer EUR 13.74B 2.01B Mar/2025
Beiersdorf EUR 2.69B 390M Mar/2025
Corteva USD 4.61B 632M Mar/2025
Covestro EUR 3.47B 90M Mar/2025
Essilor EUR 6.85B 6.44B Dec/2024
Fresenius EUR 5.65B 150M Mar/2025
Fresenius Medical Care EUR 4.88B 190M Mar/2025
Genmab DKK 5.28B 59.13B Mar/2025
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 7.52B 600M Mar/2025
GRIFOLS EUR 1.79B 150M Mar/2025
Henkel EUR 5.24B 40M Mar/2025
Hikma Pharmaceutical USD 1.57B 121M Jun/2024
Johnson Matthey GBP 5.63B 680M Sep/2024
Linde USD 8.28B 74M Dec/2024
Lonza CHF 3.06B 580M Jun/2024
Merck EUR 5.42B 152M Dec/2024
Novartis USD 13.15B 330M Dec/2024
Nutrien USD 6.72B 500M Mar/2025
Philips EUR 4.1B 947M Mar/2025
PPG Industries USD 3.68B 50M Mar/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sanofi EUR 9.9B 660M Mar/2025
SAP EUR 9.01B 367M Mar/2025
Solvay EUR 1.12B 10M Mar/2025
UCB EUR 2.79B 127M Jun/2024
Umicore EUR 1.66B 140M Dec/2024
Vinci EUR 16.32B 17.46B Dec/2024